TKNO

Alpha Teknova, Inc. [TKNO] Stock Forecast

Q: What is Alpha Teknova, Inc. stock symbol ?

Alpha Teknova, Inc. is a US stock, located in Hollister of Ca and trading under the symbol TKNO

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

TKNO Stock Summary

Earnings have grown 12.27% per last year.

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 quarters (Quarter statements)

Profit margins (-0.87%) are lower than the previous year (-0.27%)

TKNO has less than 1 year of cash runway

An RSI reading of 30 or below indicates an oversold or undervalued condition.

Top TKNO Correlated Resources

TKNO

Top 10 Correlated ETFs

TKNO

Top 10 Correlated Stocks

TKNO

In the News

08:04 22 Mar 2023 TKNO

Alpha Teknova, Inc. (TKNO) Q4 2022 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q4 2022 Results Conference Call March 15, 2023 5:00 PM ET Company Participants Jen Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matt Lowell - Chief Financial Officer Conference Call Participants Joseph Flanagan - Cowen Matt Larew - William Blair Hannah Hefley - Stephens Operator Thank you for standing by, and welcome to Teknova's Fourth Quarter and Full Year 2022 Financial Results Call. At this time, all participants are in a listen-only mode.

08:02 22 Mar 2023 TKNO

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

08:00 22 Mar 2023 TKNO

Teknova to Participate in Upcoming Investor Conferences

HOLLISTER, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conferences:

04:42 22 Mar 2023 TKNO

Alpha Teknova, Inc. (TKNO) Q3 2022 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q3 2022 Earnings Conference Call November 21, 2022 4:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Teknova Third Quarter 2022 Financial Results Conference Call.

04:01 22 Mar 2023 TKNO

Teknova to Participate in Upcoming Investor Conferences

HOLLISTER, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, research, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conferences:

04:01 22 Mar 2023 TKNO

Teknova to Report Third Quarter 2022 Financial Results on November 9, 2022

HOLLISTER, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2022, on Wednesday, November 9, 2022, following the close of market.

04:01 22 Mar 2023 TKNO

Teknova to Participate in Upcoming Investor Conference

HOLLISTER, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conference.

07:43 22 Mar 2023 TKNO

Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q2 2022 Results - Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Stephanie Yan - Cowen Matt Larew - William Blair Jake Johnson - Stephens Operator Good day, and thank you for standing by. Welcome to the Teknova Second Quarter 2022 Financial Results Conference Call.

04:01 22 Mar 2023 TKNO

Teknova to Report Second Quarter 2022 Financial Results on August 10, 2022

HOLLISTER, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2022, on Wednesday, August 10, 2022, following the close of market.

07:37 22 Mar 2023 TKNO

Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q1 2022 Results - Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Matthew Larew - William Blair Stephanie Yan - Cowen and Company Jacob Johnson - Stephens, Inc. Operator Good day, and thank you for standing by. Welcome to the Teknova First Quarter 2022 Financial Results Conference Call.

TKNO Financial details

Company Rating

Buy

Market Cap

90.3M

Income

-47.47M

Revenue

41.42M

Book val./share

3.99

Cash/share

1.77

Dividend

Dividend %

Employees

237

Optionable

Shortable

Yes

Earnings

09 Nov 2022

P/E

-2.42

Forward P/E

PEG

-0.09

P/S

2.1

P/B

0.82

P/C

1.84

P/FCF

-1.72

Quick Ratio

4.56

Current Ratio

5.68

Debt / Equity

0.43

LT Debt / Equity

0.4

EPS (TTM)

-1.69

EPS next Y

EPS next Q

EPS this Y

263.97%

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

Revenue Q/Q

-26.2%

EPS Q/Q

-41.25%

SMA20

-37.39%

SMA50

-35.34%

SMA100

-1.11%

Inst Own

19.19%

Inst Trans

-3.58%

ROA

-24%

ROE

-29%

ROC

-0.27%

Gross Margin

47%

Oper. Margin

-92%

Profit Margin

-87%

Payout

Shs Outstand

28.13M

Shs Float

6.93M

Target Price

52W Range

3.02-17.6

52W High

-80.82%

52W Low

+8.67%

RSI

19.2

Rel Volume

0.83

Avg Volume

46.21K

Volume

38.22K

Perf Week

-13.76%

Perf Month

-45.48%

Perf Quarter

-9.19%

Perf Half Y

-13.07%

Beta

Volatility

0.13%, 0.97%

Prev Close

3.16%

Price

3.26

Change

0.93%

TKNO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric	2019-12-31	2020-12-31	2021-12-31
Revenue per share	0.96	1.48	1.75
Net income per share	-0.06	0.17	-0.46
Operating cash flow per share	0.1	0.12	-0.43
Free cash flow per share	-0.02	-0.14	-1.37
Cash per share	0.46	0.24	0
Book value per share	2.31	2.48	0.01
Tangible book value per share	0.52	0.76	0.01
Share holders equity per share	2.31	2.48	0.01
Interest debt per share	0	0	-0.03
Market cap	525.89M	527.8M	432.37M
Enterprise value	521.79M	524.48M	432.3M
P/E ratio	-402.98	147.84	-44.11
Price to sales ratio	26.17	16.86	11.72
POCF ratio	242.12	210.7	-47.68
PFCF ratio	-1.1K	-178.25	-14.94
P/B Ratio	10.83	10.07	3.02K
PTB ratio	10.83	10.07	3.02K
EV to sales	25.97	16.76	11.72
Enterprise value over EBITDA	-2.95K	77.47	-41.8
EV to operating cash flow	240.24	209.37	-47.67
EV to free cash flow	-1.09K	-177.13	-14.93
Earnings yield	0	0.01	-0.02
Free cash flow yield	0	-0.01	-0.07
Debt to equity	0.21	0.2	0.16
Debt to assets	0.17	0.17	0.14
Net debt to EBITDA	23.16	-0.49	0.01
Current ratio	2.76	4.14	13.07
Interest coverage	0	0	20.39
Income quality	-1.66	0.7	0.93
Dividend Yield	0	0	0
Payout ratio	0	0	0
Sales general and administrative to revenue	0.38	0.26	0.55
Research and developement to revenue	0.04	0.05	0.12
Intangibles to total assets	0.64	0.58	0.21
Capex to operating cash flow	-1.22	-2.18	2.19
Capex to revenue	-0.13	-0.17	-0.54
Capex to depreciation	-1.63	-2.67	-6.89
Stock based compensation to revenue	0	0.01	0.04
Graham number	1.79	3.07	0.27
ROIC	-0.03	0.06	864.67
Return on tangible assets	-0.06	0.13	-74.72
Graham Net	0.15	0.06	0
Working capital	9.84M	12.45M	93.46K
Tangible asset value	10.94M	15.94M	107.89K
Net current asset value	5.45M	5.91M	77.9K
Invested capital	0	0	0.08
Average receivables	0	4.78M	3.29M
Average payables	0	1.2M	818.62K
Average inventory	0	3.07M	1.79M
Days sales outstanding	54.24	76.61	0.05
Days payables outstanding	24.33	44.07	0.04
Days of inventory on hand	81.3	96.55	0.1
Receivables turnover	6.73	4.76	7.91K
Payables turnover	15	8.28	8.57K
Inventory turnover	4.49	3.78	3.57K
ROE	-0.03	0.07	-68.46
Capex per share	-0.13	-0.26	-0.94

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric	2021-09-30	2021-12-31	2022-03-31	2022-06-30	2022-09-30
Revenue per share	0.34	0.36	0.4	0.42	0.38
Net income per share	-0.12	-0.13	-0.2	-0.22	-0.8
Operating cash flow per share	-0.17	-0.11	-0.19	-0.21	-0.3
Free cash flow per share	-0.31	-0.37	-0.4	-0.6	-0.53
Cash per share	3.5	3.12	2.73	2.31	1.77
Book value per share	5.22	5.11	4.94	4.76	3.99
Tangible book value per share	3.95	3.85	3.69	3.52	3.35
Share holders equity per share	5.22	5.11	4.94	4.76	3.99
Interest debt per share	0.42	0.42	1.14	1.3	1.28
Market cap	697.22M	573.68M	387.11M	235.69M	93.82M
Enterprise value	611.03M	498.04M	342.6M	207.37M	79.93M
P/E ratio	-53.62	-39.33	-17.61	-9.5	-1.04
Price to sales ratio	74.24	56.74	34.73	20.16	8.77
POCF ratio	-144.14	-186.14	-74.43	-40.37	-11.26
PFCF ratio	-79.74	-54.67	-34.82	-14.06	-6.29
P/B Ratio	4.77	4.01	2.79	1.77	0.84
PTB ratio	4.77	4.01	2.79	1.77	0.84
EV to sales	65.06	49.26	30.74	17.74	7.48
Enterprise value over EBITDA	-179.98	-121.65	-66.94	-35.89	-3.62
EV to operating cash flow	-126.32	-161.6	-65.87	-35.52	-9.59
EV to free cash flow	-69.88	-47.46	-30.82	-12.37	-5.36
Earnings yield	0	-0.01	-0.01	-0.03	-0.24
Free cash flow yield	-0.01	-0.02	-0.03	-0.07	-0.16
Debt to equity	0.16	0.16	0.33	0.37	0.43
Debt to assets	0.14	0.14	0.25	0.27	0.3
Net debt to EBITDA	25.39	18.48	8.7	4.9	0.63
Current ratio	17.9	13.07	7.28	6.77	5.68
Interest coverage	0	132.42	449.46	-236.64	-327.91
Income quality	1.49	0.85	0.95	0.94	0.37
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.6	0.67	0.65	0.6	0.61
Research and developement to revenue	0.15	0.14	0.18	0.17	0.18
Intangibles to total assets	0.21	0.21	0.19	0.19	0.11
Capex to operating cash flow	0.81	2.4	1.14	1.87	0.79
Capex to revenue	-0.42	-0.73	-0.53	-0.93	-0.62
Capex to depreciation	-5.22	-9.47	-7.88	-13.79	-9.03
Stock based compensation to revenue	0.05	0.06	0.07	0.08	0.09
Graham number	3.69	3.87	4.67	4.86	8.47
ROIC	0.1	0.33	-0.19	-0.12	-0.4
Return on tangible assets	-0.02	-0.03	-0.04	-0.04	-0.16
Graham Net	2.91	2.51	1.41	0.87	0.41
Working capital	104.88M	93.46M	79.3M	68.41M	57.74M
Tangible asset value	110.62M	107.89M	103.52M	98.72M	94.15M
Net current asset value	88.14M	77.9M	46.4M	31.54M	21.79M
Invested capital	0.08	0.08	0.23	0.27	0.32
Average receivables	5.72M	5.21M	5.92M	6.55M	6.15M
Average payables	2.98M	2.78M	2.64M	2.22M	2.45M
Average inventory	4.14M	4.9M	5.91M	7.17M	9.12M
Days sales outstanding	55.09	41.54	57.86	45.63	53.6
Days payables outstanding	58.27	39.43	47	19.85	52.96
Days of inventory on hand	77.26	94.61	99.75	110.48	156.88
Receivables turnover	1.63	2.17	1.56	1.97	1.68
Payables turnover	1.54	2.28	1.91	4.53	1.7
Inventory turnover	1.16	0.95	0.9	0.81	0.57
ROE	-0.02	-0.03	-0.04	-0.05	-0.2
Capex per share	-0.14	-0.26	-0.21	-0.39	-0.23

TKNO Frequently Asked Questions

What is Alpha Teknova, Inc. stock symbol ?

Alpha Teknova, Inc. is a US stock , located in Hollister of Ca and trading under the symbol TKNO

What is Alpha Teknova, Inc. stock quote today ?

Alpha Teknova, Inc. stock price is $3.26 today.

Is Alpha Teknova, Inc. stock public?

Yes, Alpha Teknova, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 46.21K
Market Capitalization 90.3M
Employee 237
CEO Mr. Stephen Gunstream
Headquarters Hollister,CA,US
IPO Date 2021-06-25
Website https://www.teknova.com

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.